NPPNY लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 22:35):
No signals from the correlation tool

Stats
आज की मात्रा	2 387
औसत मात्रा	523
बाजार मूल्य	1.35B
EPS	$27.45 ( Q4 \| 2024-03-31 )
अगली कमाई की तारीख	( $0 ) 2024-08-08
Last Dividend	$0.105 ( 2022-09-29 )
Next Dividend	$0 ( N/A )
P/E	8.33 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACRDF 0.00%

ACRHF 0.00%

APNHY 0.00%

AVTBF 0.63%

AYRWF -14.89%

BBBT 0.00%

BLMS -9.09%

CBDHF 0.00%

CBGL 0.00%

CCHWF -21.71%

CENBF 0.00%

CHALF -99.00%

CNTTQ 0.00%

CRLBF -11.73%

CRYM -1.48%

DVAXW 9 900.00%

DVLP 0.00%

EAPH 12.03%

EDXC 55.17%

EMHTF 0.00%

ESALF -2.11%

ESALY 12.50%

ETST 11.90%

GDNSF -3.00%

GLASF 0.00%

GNHAY -15.36%

GRAMF 9 900.00%

HCANF 0.00%

HKMPY 0.00%

HLUYY 0.00%

HYEX -1.11%

HYPMY 0.00%

IPSEY 1.06%

ITHUF -18.67%

JUSHF 20.00%

KGKG 0.00%

LOWLF 0.00%

LVRLF 0.00%

MILC -1.14%

MKKGY -66.67%

NLBS 0.00%

NPHC 0.00%

NPPNY 0.00%

NUNZ 7.50%

ORXOY 2.13%

PLNHF 0.00%

PZOO -26.83%

RLBD 1.82%

RWBYF 0.21%

SGIOY 0.00%

TAIPY -12.10%

TCNNF 0.00%

TEVJF 0.00%

TLGTQ -11.79%

TRSSF -7.41%

UNRV -2.59%

VEXTF -13.10%

VLNCD 0.00%

VRNOF 0.00%

सहसंबंध (AI algo v.1.1b): Paired value (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Nippon Shinyaku Co., Ltd. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Nippon Shinyaku Co., Ltd. वित्तीय

Annual	2024
राजस्व:	$148.26B
सकल लाभ:	$97.02B (65.44 %)
EPS:	$383.82

FY	2024
राजस्व:	$148.26B
सकल लाभ:	$97.02B (65.44 %)
EPS:	$383.82

FY	2023
राजस्व:	$144.18B
सकल लाभ:	$88.20B (61.17 %)
EPS:	$338.70

FY	2022
राजस्व:	$137.48B
सकल लाभ:	$87.29B (63.49 %)
EPS:	$370.97

Financial Reports:

No articles found.

Nippon Shinyaku Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.105 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Nippon Shinyaku Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.47 - Stable (29.33%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0575	2017-10-02
Last Dividend	$0.105	2022-09-29
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$1.029	--
Avg. Dividend % Per Year	0.00%	--
Score	4.09	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.47
Div. Directional Score	9.92	--

Next Divdend (Est)
(2024-10-23)

$0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

4.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
29 Sep 2022	$0.105	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2022	$0.108	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Sep 2021	$0.112	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2021	$0.113	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Sep 2020	$0.118	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 Mar 2020	$0.0997	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 Sep 2019	$0.0986	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Mar 2019	$0.0950	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 Sep 2018	$0.0640	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Mar 2018	$0.0586	30 Nov -0001	30 Nov -0001	30 Nov -0001
02 Oct 2017	$0.0575	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
OSCUF	Ex Dividend Junior	2023-09-28	Annually	0.00%
BTDPY	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
KAEPF	Ex Dividend Junior	2023-09-28	Annually	0.00%
VTKLY	Ex Dividend Knight	2023-07-20	Semi-Annually	0.00%
FNFI	Ex Dividend Knight	2023-09-07	Quarterly	0.00%
RTMVY	Ex Dividend Knight	2023-09-28	Annually	0.00%
CNLPL	Ex Dividend Junior	2023-09-07	Quarterly	0.00%
MHGU	Ex Dividend Junior	2023-09-14	Semi-Annually	0.00%
ANSLY	Ex Dividend Knight	2023-08-23	Semi-Annually	0.00%
HNFSA	Ex Dividend Junior	2023-08-09	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.174	1.500	6.51	9.77	[0 - 0.5]
returnOnAssetsTTM	0.0981	1.200	6.73	8.07	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.76	10.00	[0.1 - 1]
payoutRatioTTM	0.310	-1.000	6.90	-6.90	[0 - 1]
currentRatioTTM	4.40	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.11	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.206	1.500	4.41	6.62	[0.2 - 2]
debtRatioTTM	0.0109	-1.500	9.82	-10.00	[0 - 0.6]
interestCoverageTTM	102.86	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	241.85	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	98.59	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0130	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.661	1.000	2.31	2.31	[0.2 - 0.8]
operatingProfitMarginTTM	0.228	1.000	7.45	7.45	[0.1 - 0.6]
cashFlowToDebtRatioTTM	5.67	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.563	0.800	9.58	7.66	[0.5 - 2]
Total Score				13.38

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	2.10	1.000	9.89	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	98.59	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.0000876	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	241.85	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.310	1.500	6.90	-6.90	[0 - 1]
pegRatioTTM	0.00208	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.110	1.000	9.75	0	[0.1 - 0.5]
Total Score				6.47

Nippon Shinyaku Co., Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Nippon Shinyaku Co., Ltd.

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.